Flagship explainer

How BIO-TECHNE Corp makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$1.2B · 100%Cost of revenue$416M · 34%Gross profit$799M · 66%Operating income$252M · 21%Income before tax$241M · 20%Income tax$58.8M · 5%Net income$182M · 15%As of 2026-06-30 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$1.2B100%
Cost of revenue$416M34%
$799M66%
$252M21%
Income before tax$241M20%
Income tax$58.8M5%
$182M15%
Source: · event Jun 30, 2026 · retrieved Oct 16, 2026 · annual-row source set
Embed this chart

View the full BIO-TECHNE Corp analysis at Buy Like Buffett